In juvenile polyposis, the ESGE and BSG suggest that oesophagogastroduodenoscopy surveillance starts for asymptomatic individuals with SMAD4 mutation at the age of 18, and with BMPR1A mutation at the age of 25 years. Here, BMPR1A is linked to juvenile polyposis syndrome.